top glp-1 dual agonist competitors to zepbound Use of the GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with drugs among patients with type 2 diabetes, a large retrospective cohort Zepbound vs. Mounjaro | Insulin
Description
& Engelhardt, B
Searches incorporated controlled vocabulary (e.g., Medical Subject Headings and Emtree) and Boolean operators
Can resM replace semaglutide or tirzepatide
P = 0.30) (252), and the HARMONY Outcomes trial of albiglutide indicated a similar trend in reducing total stroke (HR 0.86
This suggests that differences in factors such as bowel preparation protocols, duration of fasting or clear liquid diet, and GLP-1 RA dosing may have influenced the outcomes
Doctors from the ASA explained that the delayed gastric emptying from the drugs means there is still food in the stomach
